← Back to all trials
Completed
NCT05758948
Detection of Germline and Somatic Pathogenic Variants in Patients With de Novo Metastatic Breast Cancer
Conditions: Metastatic Breast Cancer
Sex: All
Ages: 18 Years – N/A
Healthy volunteers: No
Enrollment: 101
Sponsor: Hellenic Cooperative Oncology Group
Location: Evangelia Moirogiorgou Athens
Summary
To determine somatic and germline pathogenic variants in patients with denovo metastatic breast cancer in order to map the molecular/genetic characteristics of DN- MBC aiming in comprehending the biology and highlighting potential novel treatment options for the disease.
Eligibility Criteria
Inclusion Criteria:
1. Signed informed consent for the provision of the biological material for research purposes
2. Diagnosis of de novo MBC (histologically confirmed)
3. Age \>18 years
4. Blood samples
5. Tumor tissue block from at least on disease site, primary (preferably) or metastatic
Exclusion Criteria:
Inadequate MBC tissue
Source: ClinicalTrials.gov (NCT05758948). StuddyBuddy aggregates publicly available trial information.
